S&P 500   2,966.15 (-0.14%)
DOW   26,787.36 (-0.11%)
QQQ   191.09 (-0.01%)
AAPL   235.87 (-0.14%)
FB   183.28 (-0.49%)
MSFT   139.55 (-0.09%)
GOOGL   1,217.77 (+0.17%)
AMZN   1,736.43 (+0.26%)
CGC   18.86 (-2.93%)
NVDA   186.53 (+0.29%)
MU   44.86 (-0.53%)
BABA   171.16 (-1.03%)
GE   8.72 (-0.91%)
TSLA   256.96 (+3.66%)
AMD   30.53 (+2.62%)
T   37.47 (-0.29%)
F   8.82 (+0.46%)
ACB   3.51 (-4.62%)
PRI   121.47 (-0.18%)
NFLX   285.53 (+0.92%)
BAC   29.14 (+0.80%)
GILD   64.51 (+0.81%)
DIS   129.70 (-0.25%)
S&P 500   2,966.15 (-0.14%)
DOW   26,787.36 (-0.11%)
QQQ   191.09 (-0.01%)
AAPL   235.87 (-0.14%)
FB   183.28 (-0.49%)
MSFT   139.55 (-0.09%)
GOOGL   1,217.77 (+0.17%)
AMZN   1,736.43 (+0.26%)
CGC   18.86 (-2.93%)
NVDA   186.53 (+0.29%)
MU   44.86 (-0.53%)
BABA   171.16 (-1.03%)
GE   8.72 (-0.91%)
TSLA   256.96 (+3.66%)
AMD   30.53 (+2.62%)
T   37.47 (-0.29%)
F   8.82 (+0.46%)
ACB   3.51 (-4.62%)
PRI   121.47 (-0.18%)
NFLX   285.53 (+0.92%)
BAC   29.14 (+0.80%)
GILD   64.51 (+0.81%)
DIS   129.70 (-0.25%)
Log in

Titan Pharmaceuticals SEC Filings & 10K Form (NASDAQ:TTNP)

$0.36
-0.07 (-16.26 %)
(As of 10/14/2019 04:00 PM ET)
Today's Range
$0.35
Now: $0.36
$0.43
50-Day Range
$0.24
MA: $0.38
$0.48
52-Week Range
$0.24
Now: $0.36
$3.78
Volume2.01 million shs
Average Volume751,207 shs
Market Capitalization$6.17 million
P/E RatioN/A
Dividend YieldN/A
Beta1.18

SEC Filings

Titan Pharmaceuticals (NASDAQ:TTNP) SEC Filings

DateFilerForm TypeView
10/11/2019
12:44 PM
Titan Pharmaceuticals (Filer)
Form S-1/A
10/08/2019
4:28 PM
Titan Pharmaceuticals (Filer)
Form S-1/A
09/28/2019
2:04 AM
Titan Pharmaceuticals (Filer)
Form S-1/A
09/20/2019
10:30 AM
Titan Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/20/2019
8:44 AM
Titan Pharmaceuticals (Filer)
Form CT ORDER
09/18/2019
4:29 PM
Titan Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/12/2019
8:28 AM
Titan Pharmaceuticals (Filer)
Form S-1
Registration statement under Securities Act of 1933  
08/23/2019
10:35 AM
Titan Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/19/2019
4:27 PM
Titan Pharmaceuticals (Filer)
Form D
Notice of Exempt Offering of Securities 
08/08/2019
4:28 PM
Titan Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2019
4:26 PM
Titan Pharmaceuticals (Filer)
Form 424B5
08/08/2019
3:56 PM
Titan Pharmaceuticals (Filer)
Form 424B5
08/07/2019
11:45 AM
SABBY MANAGEMENT, LLC (Filed by)
Titan Pharmaceuticals (Subject)
Form SC 13G
06/27/2019
3:12 PM
Titan Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/07/2019
3:20 PM
Hallberg Dane (Reporting)
Titan Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2019
3:06 PM
Titan Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/25/2019
8:52 PM
Titan Pharmaceuticals (Filer)
Form 424B5
04/25/2019
8:49 PM
Titan Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/24/2019
11:15 PM
Titan Pharmaceuticals (Filer)
Form EFFECT
04/05/2019
3:35 PM
Titan Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
04/03/2019
3:30 PM
Titan Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/03/2019
3:30 PM
Rubin Marc (Reporting)
Titan Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2019
3:30 PM
BHONSLE SUNIL (Reporting)
Titan Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2019
5:05 AM
Titan Pharmaceuticals (Filer)
Form 10-K/A
04/01/2019
3:37 PM
Titan Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/25/2019
4:36 PM
Beebe Katherine (Reporting)
Titan Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/25/2019
4:35 PM
Hallberg Dane (Reporting)
Titan Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/25/2019
1:29 PM
Titan Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2019
5:10 AM
Titan Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/19/2018
6:50 PM
Titan Pharmaceuticals (Filer)
Form DEF 14A
12/06/2018
5:03 AM
Titan Pharmaceuticals (Filer)
Form PRE 14A
11/14/2018
3:03 PM
Titan Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/22/2018
4:27 PM
Titan Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/22/2018
3:38 PM
Recli Federico Seghi (Reporting)
Titan Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2018
3:51 PM
Titan Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/26/2018
4:45 PM
Recli Federico Seghi (Reporting)
Titan Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/25/2018
6:09 PM
MACFARLANE M DAVID (Reporting)
Titan Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/25/2018
6:06 PM
BHONSLE SUNIL (Reporting)
Titan Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/25/2018
6:04 PM
MCNAB JAMES R (Reporting)
Titan Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/25/2018
6:02 PM
Rubin Marc (Reporting)
Titan Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/25/2018
6:00 PM
Akers Joseph A (Reporting)
Titan Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/25/2018
4:13 PM
Titan Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/25/2018
5:06 AM
Titan Pharmaceuticals (Filer)
Form 424B3
09/20/2018
11:15 PM
Titan Pharmaceuticals (Filer)
Form EFFECT
09/20/2018
8:25 AM
Titan Pharmaceuticals (Filer)
Form S-1/A
09/20/2018
5:06 AM
Titan Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/12/2018
7:11 AM
Titan Pharmaceuticals (Filer)
Form S-1/A
09/10/2018
8:17 AM
Titan Pharmaceuticals (Subject)
Form FWP
09/10/2018
8:14 AM
Titan Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/04/2018
7:01 AM
Titan Pharmaceuticals (Subject)
Form FWP
09/04/2018
7:00 AM
Titan Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/30/2018
4:25 PM
Titan Pharmaceuticals (Filer)
Form S-1/A
08/17/2018
2:45 PM
Titan Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2018
4:30 PM
Titan Pharmaceuticals (Filer)
Form S-1
Registration statement under Securities Act of 1933  
08/08/2018
2:07 PM
Titan Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/03/2018
1:53 PM
Titan Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/31/2018
2:01 PM
Titan Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/01/2018
3:15 PM
Titan Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/30/2018
3:54 PM
Titan Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/23/2018
2:43 PM
Recli Federico Seghi (Reporting)
Titan Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/16/2018
3:15 PM
Titan Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2018
3:02 PM
Titan Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/13/2018
7:01 AM
Titan Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/02/2018
12:32 PM
Titan Pharmaceuticals (Filer)
Form CT ORDER
04/02/2018
10:01 AM
Titan Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/26/2018
2:56 PM
Titan Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/09/2018
3:37 PM
BHONSLE SUNIL (Reporting)
Titan Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/09/2018
3:35 PM
Rubin Marc (Reporting)
Titan Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2018
10:33 AM
MEAD ROBERT E (Filed by)
Titan Pharmaceuticals (Subject)
Form SC 13G/A
02/06/2018
7:05 PM
Titan Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/22/2018
1:28 PM
Titan Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2018
5:08 AM
Titan Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/07/2017
2:06 PM
Titan Pharmaceuticals (Filer)
Form CT ORDER
This page was last updated on 10/14/2019 by MarketBeat.com Staff

Featured Article: High-Yield Dividend Stocks

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel